Amanote Research
Register
Sign In
Can the Microbiome Deliver? A Proof-Of-Concept Engineered E. Coli PKU Therapeutic
Cell Host and Microbe
- United States
doi 10.1016/j.chom.2019.03.015
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Cancer Research
Virology
Microbiology
Microbiology
Parasitology
Date
April 1, 2019
Authors
Christopher J. Alteri
Publisher
Elsevier BV
Related search
Stroke Centers: Proof of Concept and the Concept of Proof
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
A RNAi-based Therapeutic Proof of Concept Targets Salmonid Whirling Disease in Vivo
PLoS ONE
Multidisciplinary
Are Capillary DBS Applicable for Therapeutic Drug Monitoring of Common Antipsychotics? A Proof of Concept
Bioanalysis
Pharmacology
Analytical Chemistry
Medical Laboratory Technology
Clinical Biochemistry
Medicine
Toxicology
Pharmaceutics
Production of Methlxanthines by Metabolically Engineered E. Coli
Genetically Engineered Probiotic for the Treatment of Phenylketonuria (PKU); Assessment of a Novel Treatment in Vitro and in the PAHenu2 Mouse Model of PKU
PLoS ONE
Multidisciplinary
Proof of Concept That Requiring Energy Labels for Dwellings Can Induce Retrofitting
Energy Economics
Energy
Economics
Econometrics
Engineered Global Regulator H-Ns Improves the Acid Tolerance of E. Coli
Microbial Cell Factories
Applied Microbiology
Biotechnology
Bioengineering
Delivery of a Survivin Promoter-Driven Antisense Survivin-Expressing Plasmid DNA as a Cancer Therapeutic: A Proof-Of-Concept Study
OncoTargets and Therapy
Oncology
Pharmacology
Proof of Concept Smart Metering
